The efficacy and tolerability of duloxetine in the treatment of anxious versus non-anxious depression: A post-hoc analysis of an open-label outpatient study

Annals of Clinical Psychiatry

Volumn 19, Issue 3, 2007, Pages 187-195

  Fava, Maurizio ^a   Martinez, James M ^b   Greist, John ^c   Marangell, Lauren B ^d   Brown, Eileen ^b   Chen, Lei ^b   Wohlreich, Madelaine M ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b ELI LILLY AND COMPANY   (United States)

^c Healthcare Technology Systems Inc   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Anxiety; Depression; Duloxetine; Serotonin uptake inhibitors

Indexed keywords

ACETYLSALICYLIC ACID; CITALOPRAM; DULOXETINE; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; IBUPROFEN; MULTIVITAMIN; NAPROXEN; PARACETAMOL; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VENLAFAXINE; ZOLPIDEM;

ABDOMINAL PAIN; ADULT; ARTICLE; BONE DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HAMILTON ANXIETY SCALE; HAMILTON SCALE; HUMAN; INFLUENZA; INSOMNIA; LIBIDO DISORDER; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MIXED ANXIETY AND DEPRESSION; MULTICENTER STUDY; NAUSEA; NEUROMUSCULAR DISEASE; NEUROTOXICITY; OUTPATIENT CARE; PATIENT SELECTION; POST HOC ANALYSIS; PRIORITY JOURNAL; REMISSION; SCORING SYSTEM; SEDATION; SIDE EFFECT; STOMACH DISCOMFORT; TREATMENT DURATION; TREATMENT RESPONSE; XEROSTOMIA;

ADULT; ANTIDEPRESSIVE AGENTS; ANXIETY; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE; OUTPATIENTS; SAFETY; THIOPHENES; TREATMENT OUTCOME;

EID: 34548304880     PISSN: 10401237     EISSN: 15473325     Source Type: Journal    
DOI: 10.1080/10401230701465178     Document Type: Article

References (25)

1. Fawcett J, Kravitz HM: Anxiety syndromes and their relationship to depressive illness. J Clin Psychiatry 1983; 44(8 Pt 2):8-11
2. Joffe RT, Bagby RM, Levitt A: Anxious and nonanxious depression. Am J Psychiatry 1993; 150(8):1257-1258
3. Vanvalkenburg C, Akiskal HS, Puzantian V, Rosenthal T: Anxious depressions. Clinical, family history, and naturalistic outcome - comparisons with panic and major depressive disorders. J Affect Disord 1984; 6(1):67-82
4. Clayton PJ, Grove WM, Coryell W, Keller M, Hirschfeld R, Fawcett J: Follow-up and family study of anxious depression. Am J Psychiatry 1991; 148(11):1512-1517
5. Tollefson GD, Holman SL, Sayler ME, Potvin JH: Fluoxetine, placebo, and tricyclic antidepressants in major depression with and without anxious features. J Clin Psychiatry 1994; 55(2):50-59
6. Fava M, Alpert JE, Carmin CN, Wisniewski SR, Trivedi MH, Biggs MM, Shores-Wilson K, Morgan D, Schwartz T, Balasubramani GK, Rush AJ: Clinical correlates and symptom patterns of anxious depression among patients with major depressive disorder in STAR*D. Psychol Med 2004; 34(7):1299-1308
7. Flint AJ, Rifat SL: Anxious depression in elderly patients. Response to antidepressant treatment. Am J Geriatr Psychiatry 1997; 5(2):107-115
8. Davidson JR, Meoni P, Haudiquet V, Cantillon M, Hackett D: Achieving remission with venlafaxine and fluoxetine in major depression: Its relationship to anxiety symptoms. Depress Anxiety 2002; 16(1):4-13
9. Fava M, Uebelacker LA, Alpert JE, Nierenberg AA, Pava J, Rosenbaum JF: Major depressive subtypes and treatment response. Biol Psychiatry 1997; 42:568-576
10. Russell JM, Koran LM, Rush J, Hirschfeld RM, Harrison W, Friedman ES, Davis S, Keller M: Effect of concurrent anxiety on response to sertraline and imipramine in patients with chronic depression. Depress Anxiety 2001; 13(1):18-27
11. Fava M, Rosenbaum JF, Hoog SL, Tepner RG, Kopp JB, Nilsson ME: Fluoxetine versus sertraline and paroxetine in major depression: Tolerability and efficacy in anxious depression. J Affect Disord 2000; 59(2):119-126
12. Bosworth HB, Hays JC, George LK, Steffens DC: Psychosocial and clinical predictors of unipolar depression outcome in older adults. Int J Geriatr Psychiatry 2002; 17(3):238-246
13. Ramana R, Paykel ES, Cooper Z, Hayhurst H, Saxty M, Surtees PG: Remission and relapse in major depression: A two-year prospective follow-up study. Psychol Med 1995; 25(6):1161-1170
14. Bymaster FP, Dreshfield-Ahmad LJ, Threlkeld PG, Shaw JL, Thompson L, Nelson DL, Hemrick-Luecke SK, Wong DT: Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors. Neuropsychopharmacology 2001; 25(6):871-880
15. Detke MJ, Lu Y, Goldstein DJ, Mcnamara RK, Demitrack MA: Duloxetine 60 mg once daily dosing versus placebo in the acute treatment of major depression. J Psychiatr Res 2002; 36(6):383-390
16. Detke MJ, Lu Y, Goldstein DJ, Hayes JR, Demitrack MA: Duloxetine, 60 mg once daily, for major depressive disorder: a randomized double-blind placebo-controlled trial. J Clin Psychiatry 2002; 63(4):308-315
17. Goldstein DJ, Mallinckrodt C, Lu Y, Demitrack MA: Duloxetine in the treatment of major depressive disorder: A double-blind clinical trial. J Clin Psychiatry 2002; 63:225-231
18. Goldstein DJ, Lu Y, Detke MJ, Wiltse C, Mallinckrodt C, Demitrack MA: Duloxetine in the treatment of depression: A double-blind placebo-controlled comparison with paroxetine. J Clin Psychopharmacol 2004; 24(4):389-399
19. Nemeroff CB, Schatzberg AF, Goldstein DJ, Detke MJ, Mallinckrodt C, Lu Y, Tran PV: Duloxetine for the treatment of major depressive disorder. Psychopharmacol Bull 2002; 36(4):106-132
20. Hamilton M: A rating scale for depression. J Neurol, Neurosurg, and Psychiatry 1960; 23:56-62
21. Guy W (Ed): ECDEU Assessment Manual for Psychopharmacology. Rev Ed DHEW Pub. No. (ADM) 7-338. Rockville, Maryland: National Institute of Mental Health; 1976
22. Fava M: Diagnosis and definition of treatment-resistant depression. Biol Psychiatry 2003; 53(8):649-659
23. Hamilton M: The assessment of anxiety states by rating. Br J Med Psychol 1959; 32(1):50-55
24. Cleary P, Guy W: Factor analysis of the Hamilton Depression Scale. Drugs Exp Clin Res 1977; 1:115-120
25. Frank E, Prien RF, Jarrett RB, Keller MB, Kupfer DJ, Lavori PW, Rush AJ, Weissman MM: Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence. Arch Gen Psychiatry 1991; 48(9):851-855